Glowing dye could improve detection, removal of prostate cancer cells
Editor's Note A fluorescent marker dye that attaches to a protein specific to prostate cancer cells could help surgeons identify and remove them in real time, BBC News reported June 9. Developed by researchers from the University of Oxford in the UK, the dye reportedly performed promisingly in a trial…
AI analysis suggest breast cancer surgery “may do more harm than good” for middle-aged patients
Editor's Note Artificial intelligence (AI)-fueled analysis of electronic health records suggests that clinical guidelines for de-escalating surgery should be extended to younger breast cancer patients. Conducted by University of Pittsburgh and UPMC Hillman Cancer Center researchers and published in JCO Clinical Cancer Informatics, the analysis suggests that “surgery involving sentinel…
AI promises to eliminate unnecessary breast cancer biopsies
Editor's Note An AI model that outperformed MRI and ultrasound in identifying patients with axillary breast cancer metastasis shows the technology’s potential to reduce the need for needle or surgical biopsies, according to developers at UT Southwestern Medical Center. In a May 21 report on their new AI model, researchers…
Surgery benefits transplant-ineligible HCC patients more than less invasive options
Editor's Note Liver resection provides a significant survival benefit over percutaneous radiofrequency ablation (PRFA) or transarterial chemoembolization (TACE) in patients with early multinodular hepatocellular carcinoma (HCC), according to findings published May 15 in JAMA Surgery. Thus, liver resection should be considered the first therapeutic option in patients with early multinodular…
Study explores link between diverticulitis and colorectal cancer
Editor's Note Using data from the Gastrointestinal Quality Improvement Consortium registry, this 2024 study provides new insights into the practice of recommending colonoscopy following diverticulitis episodes to rule out colorectal cancer (CRC), Clinical Gastroenterology and Hepatology April 24 reports. This study, which analyzed over 4.5 million colonoscopies performed in the…
FDA approves imaging drug for detecting cancer after lumpectomy
Editor's Note The US Food and Drug Administration (FDA) approved Lumisight (pegulicianine), a fluorescent imaging drug used to detect cancerous tissue during lumpectomy, on April 17. Administered intravenously prior to surgery, Lumisight is designed for use with the Lumicell Direct Visualization System (DVS) or another imaging device that is FDA-approved…
Two scandals at Harvard spotlight data fabrication problem in academic research
Editor's Note Two separate incidents of data fabrication and manipulation involving Harvard University and its affiliates might be indicative of a much larger fraud problem in the scientific research world, Vox March 1 reports. The most recent of the two incidents happened at the Harvard-affiliated Dana-Farber Cancer Institute, which faced…
Free Daily News
- Study: Education, exercise improve knee OA with or without prior surgery
- Study: Early surgery outperforms endoscopy for long-term pancreatitis
- Study: Blood thinner, NSAID combination raises bleeding risk
- Hospital financial report predicts stability, high cybersecurity costs for 2025
- IV fluid shortage drives innovation in hospital hydration practices
- FDA Class 1 recalls target anesthesia workstations, ambulatory infusion pumps, ventilators
- Five leadership lessons from an ASC CEO
- CMS final rule for CY 2025: Key updates impacting Medicare payments, quality programs
- GAO urges HHS to strengthen cybersecurity oversight
- Study: GLP-1s reduce TKA complications for non-diabetic patients with obesity